Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma.

MLA

Jun, Fu, et al. “Quantitative Proteomic Analysis Identifies Novel Regulators of Methotrexate Resistance in Choriocarcinoma.” Gynecologic Oncology, vol. 157, no. 1, Apr. 2020, pp. 268–79. EBSCOhost, https://doi.org/10.1016/j.ygyno.2020.01.013.

APA

Jun, F., Peng, Z., Zhang, Y., & Shi, D. (2020). Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma. Gynecologic Oncology, 157(1), 268–279. https://doi.org/10.1016/j.ygyno.2020.01.013

Chicago

Jun, Fu, Zheng Peng, Yi Zhang, and Dazun Shi. 2020. “Quantitative Proteomic Analysis Identifies Novel Regulators of Methotrexate Resistance in Choriocarcinoma.” Gynecologic Oncology 157 (1): 268–79. doi:10.1016/j.ygyno.2020.01.013.